Project cooperationUpdated on 7 January 2026
Looking to join a consortium as ecosystem interface partner for European ATMP Centres of Excellence networks (TOOL-07)
Development Manager at Kuopio Health Co-op.
Kuopio, Finland
About
Kuopio Health Co-op is interested in joining a consortium establishing a European network of Centres of Excellence (CoEs) for Advanced Therapy Medicinal Products (ATMPs).
While not acting as a CoE laboratory itself, Kuopio Health can contribute as a regional ecosystem interface, supporting collaboration between ATMP CoEs, companies, research organisations and healthcare providers, and facilitating integration of innovation ecosystems into the European network.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Organisation
Similar opportunities
Project cooperation
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
Kimmo Solehmainen
Development Manager at Kuopio Health Co-op.
Kuopio, Finland
Project cooperation
Nanolive – Cooperation Profile
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Yann Cotte
CEO at Nanolive
Tolochenaz, Switzerland
Project cooperation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
Kimmo Solehmainen
Development Manager at Kuopio Health Co-op.
Kuopio, Finland